Remaining Unmet Needs in the Treatment of HER2-Positive Breast Cancer


In the first segment, Dr Kaklamani and colleagues discuss the remaining unmet needs clinicians face despite recent advances in the treatment of patients with HER2-positive breast cancer.

Related Videos
Reshma Jagsi, MD, DPhil, Emory University
Jane L. Meisel, MD, Emory University
Pooja Advani, MBBS, MD, Mayo Clinic
Pooja Advani, MBBS, MD
Sarah Sammons, MD